Joined Pharmetheus in 2019, actively working in client projects and leading the Science and Policy Team.
Expertise includes statistics, model informed drug development, and trial design in therapeutic areas such as neuroscience, pain, and infectious diseases.
Experience as Global Head of Statistics and Chief Statistician at Pfizer Inc, USA, where he led quantitative assessment of late stage probabilities of technical and regulatory success through modeling and simulation for all late stage assets compared to industry or therapeutic area benchmarks. Prior to this role, he had been a member of the statistics leadership for the prior 12 years, led groups of various sizes accountable for the quality and integrity of analyses for those groups, and served as lead statistician for compounds under development.
M.Sc. in Statistics (1993) from University of Connecticut, USA.